Enovis Market Capitalization from 2010 to 2025

ENOV Stock  USD 47.27  0.25  0.53%   
Enovis Corp Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap will likely drop to about 1.5 B in 2025.
Check Enovis Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enovis Corp's main balance sheet or income statement drivers, such as Interest Expense of 21.6 M, Total Revenue of 2.5 B or Gross Profit of 882.3 M, as well as many indicators such as Price To Sales Ratio of 1.69, Dividend Yield of 0.0012 or PTB Ratio of 2.02. Enovis financial statements analysis is a perfect complement when working with Enovis Corp Valuation or Volatility modules.
  
Check out the analysis of Enovis Corp Correlation against competitors.
For more information on how to buy Enovis Stock please use our How to Invest in Enovis Corp guide.

Latest Enovis Corp's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Enovis Corp over the last few years. It is Enovis Corp's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enovis Corp's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.68 B10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Enovis Market Capitalization Regression Statistics

Arithmetic Mean2,424,916,098
Geometric Mean2,064,097,258
Coefficient Of Variation43.94
Mean Deviation863,028,086
Median2,792,204,770
Standard Deviation1,065,461,492
Sample Variance1135208.2T
Range3.8B
R-Value0.38
Mean Square Error1044155.5T
R-Squared0.14
Significance0.15
Slope84,190,718
Total Sum of Squares17028122.9T

Enovis Market Capitalization History

20251.5 B
20242.7 B
20233.1 B
20222.9 B
2021B
2020B
20192.8 B

About Enovis Corp Financial Statements

Enovis Corp investors use historical fundamental indicators, such as Enovis Corp's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Enovis Corp. Please read more on our technical analysis and fundamental analysis pages.
Enovis Corporation operates as a medical technology company worldwide. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies and directly under the DJO brand. Enovis Corp operates under Specialty Industrial Machinery classification in the United States and is traded on New York Stock Exchange. It employs 16200 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Enovis Stock Analysis

When running Enovis Corp's price analysis, check to measure Enovis Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enovis Corp is operating at the current time. Most of Enovis Corp's value examination focuses on studying past and present price action to predict the probability of Enovis Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enovis Corp's price. Additionally, you may evaluate how the addition of Enovis Corp to your portfolios can decrease your overall portfolio volatility.